NTx Raises $47.5M in Series B Funding to Advance Next Generation Biomanufacturing
RA Capital Management led the financing with strong participation from Series A lead investor, Anzu Partners and long-standing investor BlueStone Venture Partners.
GelSight Unveils New GelSight Mobile Shock Protected Edition
Ruggedized to withstand harsh environments, the newest addition to GelSight’s product line up brings even more resilient 3D surface analysis tools to the field and the production line
Liquid Instruments Enhances Multi-instrument Capabilities, Adds New Instrument Across Test Device Portfolio
Moku Version 3.1 also brings a range of other software upgrades to the company’s class-leading test and measurement products, strengthening applications from audio engineering to lock-in detection
6K Energy Announces the Creation of the “6K for 6K Scholars” with Lane College
The first scholarship winner, Amashia Mabone, is to be honored on November 10th at the 6K Energy office in Jackson, TN
BioSkryb Genomics to Present New Single-Cell Multiomic Data at ASHG 2023
BioSkryb will participate in two CoLab Sessions on single-cell whole genome sequencing and four poster presentations with new pancreatic and breast cancer data
Excision BioTherapeutics Presents Positive Interim Clinical Data from Ongoing Phase 1/2 Trial of EBT-101 for the Treatment of HIV at ESGCT 30th Annual Congress
Excision reported positive safety and biodistribution data to 48 weeks in the first-in-human Phase 1/2 clinical evaluation of EBT-101
Niron Magnetics’ Clean Earth Magnet Named to TIME’s List of the Best Inventions of 2023
Recognition as one of 200 world-changing innovations validates the need for Niron Magnetics’ rare earth-free magnet technology as demand for permanent magnets rises
AM Batteries Nabs Industry Veterans from Tesla, Celgard to Mass Produce Low CO2 Footprint Li-ion EV Batteries
AM Batteries appoints former president of Celgard, Lie Shi, as CEO and Maxwell, GE and Tesla Veteran, Hieu Duong, as Chief Manufacturing Officer
Excision BioTherapeutics Announces Presentation of Interim Clinical Data for EBT-101 in Latent HIV at Upcoming European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) — Excision BioTherapeutics Inc., a clinical-stage biotechnology company developing CRISPR-based therapies to cure viral infectious diseases, today announced that interim clinical safety and biodistribution data will be presented at the 30th European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress, which will be held from October 24-27, 2023, […]
ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed Research
ImmunoScape’s platform accelerates the discovery of efficacious TCR-based therapeutics for solid tumors